)
Coya Therapeutics (COYA) investor relations material
Coya Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 25, 2026, to be held virtually at 12:00 p.m. C.T.
Proxy materials and annual report for the year ended December 31, 2025, are available online for review and voting.
Shareholders are encouraged to review all proxy materials before voting and can opt for electronic delivery to support environmental initiatives.
Voting matters and shareholder proposals
Election of two directors: Wilbur Ross and Dieter Weinand, with board recommending a vote FOR both.
Ratification of Weaver and Tidwell, L.L.P. as independent registered public accounting firm for the year ending December 31, 2026, recommended by the board.
Board of directors and corporate governance
Board of Directors has provided recommendations for all voting items, supporting all nominees and auditor ratification.
- Virtual meeting to elect directors and ratify auditor, with strong governance and compensation policies.COYA
Proxy filing13 May 2026 - Q1 2026 saw FDA Fast Track, narrowed net loss, and $50.7M cash runway into H2 2027.COYA
Q1 202612 May 2026 - Treg-focused combination therapies show promise in neurodegeneration with pivotal trials underway.COYA
Investor presentation12 May 2026 - Treg-focused combination therapies show promise in neurodegeneration, with pivotal trials underway.COYA
Corporate presentation1 May 2026 - Treg-focused therapies show promise in neurodegeneration, with pivotal trials underway.COYA
Investor presentation2 Apr 2026 - Resale registration for 2.5M shares from a private placement; no proceeds to the company.COYA
Registration Filing16 Mar 2026 - Clinical progress and financing extended cash runway into 2H 2027 despite higher net loss.COYA
Q4 202516 Mar 2026 - Treg-based therapies advance in neurodegeneration with promising data and major milestones ahead.COYA
Status update5 Mar 2026 - Lead asset advanced, promising FTD data, and major licensing deal set stage for 2026 growth.COYA
Evercore ISI 8th Annual HealthCONx Conference3 Feb 2026
Next Coya Therapeutics earnings date
Next Coya Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)